This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Celgene Corporation. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Xiankang Hong: Innovator in Cancer Treatment
Introduction
Xiankang Hong is a notable inventor based in Bridgewater, NJ (US). He has made significant contributions to the field of cancer treatment through his innovative research and patent.
Latest Patents
Xiankang Hong holds a patent for a method titled "Combination therapy for the treatment of cancer." This patent outlines methods for treating and managing cancers by administering Compound A, or its enantiomers, in combination with daratumumab. Additionally, the patent includes methods that involve administering Compound A alongside daratumumab and dexamethasone. This innovative approach aims to enhance the effectiveness of cancer therapies.
Career Highlights
Xiankang Hong is associated with Celgene Corporation, a leading biopharmaceutical company known for its focus on innovative therapies for cancer and other serious diseases. His work at Celgene has positioned him as a key player in the development of advanced cancer treatments.
Collaborations
Some of his notable coworkers include Michael D Amatangelo and Chad Bjorklund. Their collaboration has likely contributed to the advancement of research and development in cancer therapies.
Conclusion
Xiankang Hong's contributions to cancer treatment through his patent and work at Celgene Corporation highlight his role as an important innovator in the medical field. His research continues to pave the way for more effective cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile